David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$415M |
| 2 |
Qualcomm
QCOM
|
+$214M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
+$114M |
| 4 |
Applied Materials
AMAT
|
+$94.5M |
| 5 |
Autodesk
ADSK
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$747M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$106M |
| 3 |
GlobalFoundries
GFS
|
+$48.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 70.28% |
| 2 | Industrials | 11.38% |
| 3 | Consumer Discretionary | 11.11% |
| 4 | Healthcare | 6.7% |
| 5 | Materials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$5.2T
| $1.34B | 15.55% |
31,637,000
-22,509,000
| -42% | -$747M |
|
|
2
GlobalFoundries
GFS
$26.4B
| $1.1B | 12.79% |
17,048,000
-800,000
| -4% | -$48.4M |
|
|
3
Applied Materials
AMAT
$391B
| $1.02B | 11.84% |
7,052,700
+755,000
| +12% | +$94.5M |
|
4
TransDigm Group
TDG
$66.4B
| $979M | 11.38% |
1,094,900
| – | – |
|
5
Amazon
AMZN
$2.79T
| $956M | 11.11% |
7,335,828
| – | – |
|
|
ALTR
6
DELISTED
Altair Engineering Inc
ALTR
| $847M | 9.85% |
11,174,200
| – | – |
|
|
7
Marvell Technology
MRVL
$213B
| $510M | 5.93% |
+8,532,697
| New | +$415M |
|
|
8
Zentalis Pharmaceuticals
ZNTL
$363M
| $394M | 4.58% |
13,959,973
+4,760,000
| +52% | +$114M |
|
9
ASML
ASML
$677B
| $360M | 4.19% |
497,200
| – | – |
|
10
Workday
WDAY
$49.4B
| $358M | 4.16% |
1,586,043
| – | – |
|
11
Synopsys
SNPS
$76.2B
| $265M | 3.08% |
609,735
| – | – |
|
|
12
Qualcomm
QCOM
$169B
| $222M | 2.57% |
+1,861,000
| New | +$214M |
|
13
Adaptive Biotechnologies
ADPT
$4.15B
| $77.7M | 0.9% |
11,572,590
| – | – |
|
14
Aura Biosciences
AURA
$809M
| $66.2M | 0.77% |
5,362,870
| – | – |
|
15
Perimeter Solutions
PRM
$5.15B
| $45.9M | 0.53% |
7,462,500
| – | – |
|
|
ADAP
16
DELISTED
Adaptimmune Therapeutics
ADAP
| $36.1M | 0.42% |
38,974,185
| – | – |
|
|
17
Autodesk
ADSK
$53.6B
| $24.3M | 0.28% |
+119,000
| New | +$23.8M |
|
|
VTYX
18
DELISTED
Ventyx Biosciences
VTYX
| $2.95M | 0.03% |
89,900
| – | – |
|
19
Zscaler
ZS
$29.4B
| $2.69M | 0.03% |
18,405
| – | – |
|
|
20
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| – | – |
-2,564,000
| Closed | -$106M |
|
Similar funds
David Goel's Q2 2023 Portfolio in Review
As of Q2 2023, David Goel held 20 positions worth $8.61B, up 17% from $7.36B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
David Goel's Q2 2023 filing shows 3 new, 2 increased, 2 reduced and 1 closed positions. Its largest new stake was Marvell Technology: 8,532,697 shares worth $510M. The largest sale was NVIDIA, an estimated $747M.
By sector, the portfolio is most concentrated in Technology at 70% of assets, down from 72% a quarter earlier, followed by Industrials and Consumer Discretionary.
- David Goel's largest Q2 2023 buy was Marvell Technology: 8,532,697 shares worth $510M.
- David Goel added most to Zentalis Pharmaceuticals in Q2 2023, an estimated $114M increase.
- David Goel's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $747M.
- David Goel fully exited State Street Energy Select Sector SPDR ETF in Q2 2023, selling an estimated $106M.
- David Goel's ten largest holdings make up 91% of its $8.61B portfolio in Q2 2023.
- David Goel opened 3 new positions and closed 1 in Q2 2023.
- David Goel's portfolio value rose 17% quarter-over-quarter to $8.61B.
Based on Matrix Capital Management Company's 13F filing for Q2 2023, filed 14 Aug 2023.